Глава 7

Ainslie, P.N., Cotter, J.D., George, K.P, Lucas, S., Murrell, C., Shave, R. Thomas, K.N., Williams, M.J., Atkinson, G. 2008. Elevation in cerebral blood flow velocity with aerobic fitness throughout healthy human aging. Journal of Physiology 586(16):4005-10.

Alumad, A.M., Hopkins, M.T., Weston, P.J., Fraser, W.D., Vora, J.P. 2002. Effects of GH replacement on 24-h ambulatory blood pressure an its circadian rhythm in adult GH deficiency. Clinical Endocrinology (Oxf) 56(4):431-7.

Arnold, S., Beyer, C. 2009. Neuroprotection by estrogen in the brain: the mitochondrial compartment as presumed therapeutic target. Journal of Neurochemistry May 29. (Epub ahead of print).

Baca-Garcia, E., Diaz-Sastre, C., de Leon, J., Saiz-Ruiz, J. 2000. The relationship between menstrual cycle phases and suicide attempts. Psychosomatic Medicine 62:50–60.

Barron, A.M., Fuller, S.J., Verdile, G., Martins, R.N. 2006. Reproductive hormones modulate oxidative stress in Alzheimer’s disease. Antioxidants 8c Redox Signaling 8(ll-12):2047-59.

Bergemann, N., Parzer, P., Nagl, I., Salbach, B. Mundt, Ch., Resch, F. 2002. Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Journal Archives of Womens Mental Health 5(3):119–126.

Bialek, M., Zaremba, P., Borowicz, K.K., Czuczwar, S.J. 2004. Neuroprotective role of testosterone in the nervous system. Polish Journal of Pharmacology 56(5):509-18.

Bosevski, M., Tosev, S., Sadikario, S. 2008. Premature atherosclerosis in patients with growth hormone deficiency and diabetes mellitus. Bratisl Lek Listy 109(6):279-80.

Braverman, E.R., Chen, T., Prihoda, T., Sonntag, W., Meshkin, B. Downs, W., Mengucci, J., Blum, S., Notaro, A., Arcuri, V., Varshavskiy, M. Blum, K. 2007. Plasma growth hormones, p300 event-related potential and test of variables of attention (t.o.v.a) are important neuroendocrinological predictors of early cognitive decline in clinical setting: evidence supported by structural equation modeling parameter estimates. Age 29(2–3):55–67.

Bush, A.L., Allen, P.A., Kaut, K.P., Ogrocki, P.K. 2007. Influence of mild cognitive impairment on visual word recognition. Neuropsychoogy, Development, and Cognition Section B Aging, Neuropsychology and Cognition 14(4):329-52.

Colao, A., Di Somma, C., Spiezia, S., Savastano, S., Rota, E, Savanelli, M.C., Lombardi, G. 2008. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. Journal of Clinical Endocrinology & Metabolism 93(9):3416-24.

Colao, A., Di Somma, C. Cascella, T., Pivonello, R. Vitale, G., Grasso, L.F., Lombardi, G., Savastano, S. 2008. Relationship between serum IGF1 levels, blood pressure, and glucose tolerance: an observational, exploratory study in 404 subjects. European Journal of Endocrinology 159(4):389-97.

Doncarlos, L.L., Azcoitia, I., Garcia-Segura, L.M. 2009. Neuroprotective actions of selective estrogen receptor modulators. Psychoneuroendocrinology May 15. [Epub ahead of print].

Elliott, S.S., Keim, N.L., Stern, J.S., Teff, K., Havel, P.J. 2002. Fructose, weight gain, and the insulin resistance syndrome. American Journal of Clinical Nutrition 76(5):911–922.

Gao, Q., et al. 2007. Anorectic estrogen mimics leptin’s effect on the rewiring of melanocortin cells and Stat3 signaling in obese animals. Nature Medicine 13(1):89–94.

Giovannini, S., Marzetti, E., Borst, S.E., Leeuwenburgh, C. 2008. Modulation of GH/IGF-1 axis: Potential strategies to counteract sarcopenia in older adults. Mechanisms of Ageing and Development 129(10):593–601.

Gomez, J.M. 2008. Growth hormone and insulin-like growth factor-I as an endocrine axis in Alzheimer’s disease. Endocrine, Metabolic & Immune Disorders — Drug Targets 8(2): 143-51.

Golgeli, A., Tanriverdi, F. Suer, C., Gokce, C., Ozesmi, C., Bayram, F., Kelestimur, F. 2004. Utility of P300 auditory event related potential latency in detecting cognitive dysfunction in growth hormone (GH) deficient patients with Sheehans syndrome and effects of GH replacement therapy. European Journal of Endocrinology 150(2):153-9.

Horan, M., Pendleton, N., Jackson, A. Lunn, D., Rabitt, P., Mogapi, O., Scott, M. Thacker, N., Lowe, C. 2007. Effects of global atrophy, white matter lesions, and cerebral blood flow on age-related changes in speed, memory, intelligence, vocabulary, and frontal function. Neuropsychology 21(6):684-95.

Hunt, K.J., et al. 2006. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study. Annals of Epidemiology 16(7):563—71.

Kearney, T. et al. 2003. Effects of short- and long-term growth hormone replacement on lipoprotein composition and on very-low-density lipoprotein and low-density lipoprotein apolipoprotein B100 kinetics in growth hormone-deficient hypopituitary subjects. Metabolism 52(l):50-9.

Ling, F.A., Hui, D.Z., Ji, S.M. 2007. Protective effect of recombinant human somatotropin on amyloid beta peptide induced learning and memory deficits in mice. Growth Hormone & IGF Research 17(4):336-41.

Loucks, T.L., Berga, S.L. 2009. Does postmenopausal estrogen use confer neuroprotection? Seminars In Reproductive Medicine 27(3):260-74.

Michaels, Jillian. Master Your Metabolism. New York: Crown Publishers, 2009.

Nguyen, T.V., Yao, M., Pike, C.J. 2005. Androgens activate mitogen- activated protein kinase signaling: role in neuroprotection. Journal of Neurochemistry 94(6):1639-51.

Rodeheffer, R.J., Gerstenblith, G., Becker, L.C., Fleg, J.L., Weisfeldt, M.L., Lakatta, E.G. 1984. Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. Circulation 69(2):203-13.

Rolland, Y. et al. 2008. Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. Journal of Nutrition, Health and Aging 12(5):335-46.

Rosario, E.R., Chang, L., Head, E.H., Stanczyk, F.Z., Pike, C.J. 2009. Brain levels of sex steroid hormones in men and women during normal aging and in Alzheimer’s disease. Neurobiology of Aging May 8. [Epub ahead of print],

Rudman, D., Feller, A.G., Nagraj, H.S., Gergans, G.A., Lalitha, P.Y., Goldberg, A.F., Schlenker, R.A., Cohn, L., Rudman, I.W., Mattson, D.E. 1990. Effects of human growth hormone in men over 60 years old. New England Journal of Medicine 323(l):l-6.

Rasmussen, M.H., Wildschiodtz, G., Juul, A., Hilsted, J. 2008. Polysomnographic sleep, growth hormone insulin-like growth factor-I axis, leptin, and weight loss. Obesity 16:1516–1521.

Schaffer, A., et al. 2007. Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia. Cancer Epidemiology Biomarkers 8c Prevention 16(4):716-22.

Tenover, J.S. 2003. Declining testicular function in aging men. International Journal of Impotence Research 15(Suppl 4):S3-S8.

Villareal, D.T., Holloszy, J.O. 2004. Effect of DHEA on abdominal fat and insulin action in elderly women and men. JAMA 292(18):2243–2248.